AXLA — Axcella Health Share News
0.000.00%
Last trade - 00:00U.S. STOCKS ON THE MOVE-Oil stocks, AMD, Walmart, Lockheed Martin, Moderna
Brief: Axcella Therapeutics Announces FDA Fast Track Designation For Axa1125 In Nash
Axcella rises on FDA fast track tag for NASH therapy
Brief: Axcella Therapeutics Announces Appointment Of New Chief Financial Officer
Brief: Axcella Therapeutics Details Clinical And Operational Milestones For 2022
Brief: Axcella Therapeutics Announces Initiation of AXA1125 Long COVID Phase 2a Clinical Trial
Axcella Health Inc reports results for the quarter ended in September - Earnings Summary
Brief: Axcella Therapeutics Reports Qtrly Loss Per Share $0.41
Brief: Axcella Health CFO Notified Co Of His Resignation Effective As Of Nov 28
Axcella Health Inc expected to post a loss of 46 cents a share - Earnings Preview
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:24 PM
Brief: Axcella Health Inc Says On September 2, Entered Into Loan And Security Agreement With Slr Investment Corp
U.S. RESEARCH ROUNDUP-Allegiant Travel Co, Citrix Systems, Helmerich and Payne
Axcella Health Inc reports results for the quarter ended in June - Earnings Summary
Axcella Health Inc expected to post a loss of 43 cents a share - Earnings Preview
Axcella rises on launching mid-stage trial of liver disease treatment
Brief: Axcella Announces Initiation Of Emmpower℠ Phase 2 Clinical Trial Of Axa1665
Brief: Axcella Announces Initiation Of EMMPACTSM Phase 2B Clinical Trial Of AXA1125
Axcella Health Inc reports results for the quarter ended in March - Earnings Summary